Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Yes Hearing Announces Expansion of Integrated Home-Based Care Services for Health Plans
Yes Hearing, leading provider of affordable, accessible, and convenient hearing technology and audiology care, has […]
EIB and MedinCell Sign a New €40 Million Loan Agreement to Support Development of Innovative Treatments
European Investment Bank (EIB), backed by the Investment Plan for Europe, and pharmaceutical company MedinCell, […]
The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio
The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers […]
Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology for Large-scale Exosome Production
Sartorius BIA Separations, a leading bio-chromatography company, now part of the international life science group […]
Nanostics Announces New Member of Board of Directors
Nanostics, a precision health diagnostics company, announced today the appointment of Aubrey Rankin to its Board […]
Nyra Medical Announces $20 Million Series A Funding for its Transcatheter Heart Valve Repair Technology
Nyra Medical, a medical device company that is developing a novel transcatheter mitral valve repair […]
Clarify Pharma Acquires Shares in Atai Life Sciences and Compass Pathways
Clarify Pharma, an investment vehicle specialising in biotech and life sciences companies seeking to prove […]
Hemispherian Raises First Tranche of Series A to Fund the Development of its Novel Cancer Therapeutics
Hemispherian AS, a Norwegian preclinical pharmaceutical company focused on small molecule cancer therapeutics targeting the […]
Eden Pharma Announces the Appointment of Mike Parker to Board of Directors
Eden Pharma, the company disrupting the CBD health and wellness industry, announces the appointment of Mike […]
NHS To Roll Out Life-Extending Drug For Advanced Gastroesophageal Cancer
NHS comments on NICE decision to approve Nivolumab to treat rare forms of gastroesophageal cancer […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more